期刊文献+

2型糖尿病肾病患者发生颈动脉粥样硬化危险因素分析 被引量:1

Analysis of risk factors for carotid atherosclerosis in patients with type 2 diabetic nephropathy
下载PDF
导出
摘要 目的探讨2型糖尿病肾病患者发生颈动脉粥样硬化的危险因素。方法选择2015年1月至2020年1月新乡市中心医院收治的2型糖尿病肾病患者共214例为研究对象。所有患者常规行颈动脉彩色多普勒超声检查,根据检查结果将患者分为非动脉粥样硬化组(n=40)和动脉粥样硬化组(n=174)。所有患者常规行多导睡眠监测,判断是否存在阻塞性呼吸睡眠暂停(OSA);常规监测并记录所有患者的血压、糖化血红蛋白(HbA1c)、血糖、血脂、血尿素氮、血肌酐、24 h尿蛋白定量,计算体质量指数(BMI)及估算的肾小球滤过率(eGFR)。比较2组患者上述各指标的差异,将差异有统计学意义的指标进一步行logistic回归分析筛选颈动脉粥样硬化发生的危险因素。结果214例2型糖尿病肾病患者中共有174例发生颈动脉粥样硬化,发生率为81.3%。2组患者的年龄、性别分布、HbA1c、eGFR比较差异无统计学意义(P>0.05),2组患者的BMI、收缩压、舒张压、三酰甘油、胆固醇、低密度脂蛋白、24 h尿蛋白定量及OSA发生比例比较差异均有统计学意义(P<0.05)。Logistic回归分析结果显示,收缩压、舒张压、三酰甘油、合并OSA是2型糖尿病肾病患者发生颈动脉粥样硬化的危险因素(P<0.05)。结论高血压、高血脂及合并OSA是2型糖尿病肾病患者发生颈动脉粥样硬化的危险因素,积极控制血压、血脂及治疗OSA可预防或改善颈动脉粥样硬化的发生、发展。 Objective To explore the risk factors of carotid atherosclerosis in patients with type 2 diabetic nephropathy.Methods A total of 214 patients with type 2 diabetic nephropathy admitted to Xinxiang Central Hospital from January 2015 to January 2020 were selected as the research objects.All patients underwent routine carotid artery color Doppler ultrasonography examination and were divided into non-atherosclerosis group(n=40)and atherosclerosis group(n=174)according to the examination results.All patients underwent routine polysomnography to determine whether there was obstructive sleep apnea(OSA).Blood pressure,glycosylated hemoglobin(HbA1c),blood glucose,blood lipid,blood urea nitrogen,serum creatinine,24-hours urinary protein,body mass index(BMI)and estimated glomerular filtration rate(eGFR)of all patients were monitored and recorded.The difference of the above indexes between the two groups were compared,and the statistically significant indexes were further analyzed by logistic regression to screen the risk factors of carotid atherosclerosis.Results There were 174(81.3%)cases of carotid atherosclerosis in the 214 patients with type 2 diabetic nephropathy.There was no significant difference in age,gender distribution,HbA1c and eGFR between the two groups(P>0.05);there was significant difference in BMI,systolic blood pressure,diastolic blood pressure,triglyceride,cholesterol,low-density lipoprotein,24-hours urinary protein and the incidence of OSA between the two groups(P<0.05).Logistic regression analysis showed that systolic blood pressure,diastolic blood pressure,triglyceride and combination of OSA were risk factors of carotid atherosclerosis in patients with type 2 diabetic nephropathy(P<0.05).Conclusion Hypertension,hyperlipidemia and combination of OSA are risk factors of carotid atherosclerosis in patients with type 2 diabetic nephropathy.Active treatment of blood pressure,blood lipid and OSA may prevent or improve the occurrence and development of carotid atherosclerosis.
作者 王焕 崔凯 尤冠巧 郭利芹 徐可 布海霞 WANG Huan;CUI Kai;YOU Guanqiao;GUO Liqin;XU Ke;BU Haixia(Department of Nephrology,Xinxiang Central Hospital,Xinxiang 453000,Henan Province,China;Department of General Tumor Surgery,Xinxiang Central Hospital,Xinxiang 453000,Henan Province,China;Department of Nephrology,Henan Provincial People′s Hospital,Zhengzhou 450000,Henan Province,China)
出处 《新乡医学院学报》 CAS 2021年第6期531-533,539,共4页 Journal of Xinxiang Medical University
基金 河南省科技攻关计划项目(编号:201503150)。
关键词 糖尿病肾病 阻塞性呼吸睡眠暂停 颈动脉粥样硬化 diabetic nephropathy obstructive sleep apnea carotid atherosclerosis
  • 相关文献

参考文献1

二级参考文献16

  • 1侯凡凡.慢性肾脏病的心血管并发症[J].中华心血管病杂志,2004,32:16-16. 被引量:11
  • 2何长民 张训 见:何长民 张训主编.前言[A].见:何长民,张训主编.肾脏替代治疗学[C].上海:上海科学技术文献出版社,1999.2.. 被引量:1
  • 3Locatelli F, Pozzoni P, Tentori F, et al. Epidemiology of cardiovascular risk in patients with chronic kidney disease. Nephrol Dial Transplant, 2003,18 Suppl 7:2-9. 被引量:1
  • 4Muntner P, He J, Hamm L, et al. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol, 2002,13:745-753. 被引量:1
  • 5Manjunath G, Tighiouart H, Ibrahim H, et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol, 2003,41:47-55. 被引量:1
  • 6Foley RN, Parfrey PS, Harnett JD, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int, 1995,47:186-192. 被引量:1
  • 7Sarnak MJ, Levey AS, Schoolwerth AC,et al. Kidney disease as a risk factor for development of cardiovascular disease. A statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation, 2003,108:2154-2169. 被引量:1
  • 8Foley RN, Herzog CA, Collins AJ. Smoking and cardiovascular outcomes in dialysis patients: the United States Renal Data System Wave 2 Study. Kidney Int, 2003,63:1462-1467. 被引量:1
  • 9Wong JS, Rort FK, Hulbert-Shearon TE, et al. Survival advantage in Asian American end-stage renal disease patients. Kidney Int, 1999,55:2515-2523. 被引量:1
  • 10Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis, 1998,32:s112-s119. 被引量:1

共引文献181

同被引文献17

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部